Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

OBJECTIVES: To systematically review the impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and severe adverse events (SAEs) in patients with rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) in remission or low disease activity (LDA) state. MATERIA...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Res Ther
Autori principali: Vinson, D., Molet-Benhamou, L., Degboé, Y., den Broeder, A., Ibrahim, F., Pontes, C., Westhovens, R., Závada, J., Pham, T., Barnetche, T., Constantin, A., Ruyssen-Witrand, A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7191828/
https://ncbi.nlm.nih.gov/pubmed/32349791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02188-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi